Instructions for Enterosgel Extracaps capsules 0.32 g No. 7
Composition
active ingredient: polymethylsiloxane xerogel;
1 capsule contains 0.32 g of polymethylsiloxane xerogel;
excipients: gelatin, titanium dioxide (E 171).
Dosage form
Capsules for oral use.
Main physicochemical properties: hard gelatin capsules, white body and cap. Capsule contents - white or almost white powder, odorless.
Pharmacotherapeutic group
Enterosorbents. ATX code A07V S.
Pharmacological properties
Pharmacodynamics
When used internally, it has a detoxifying effect. The drug effectively adsorbs medium-molecular toxic substances, products of incomplete metabolism from the contents of the intestines and blood (through the membranes of the capillaries of the intestinal mucosal villi), promotes the excretion of incorporated radionuclides. Enterosgel ExtraCaps eliminates the manifestations of toxicosis, improves the function of the intestines, liver, kidneys, normalizes blood and urine parameters. As an effective detoxifier, Enterosgel ExtraCaps helps to increase immunity.
Pharmacokinetics
The drug coats the mucous membrane of the stomach and intestines, protecting it from erosive processes. It is not absorbed from the intestines.
Indication
As part of complex detoxification therapy for chronic renal failure caused by pyelonephritis, polycystic kidney disease, nephrolithiasis; for toxic hepatitis, viral hepatitis A and B, hepatocholecystitis, liver cirrhosis and cholestasis of various etiologies, gastritis with low acidity, enterocolitis, colitis, diarrhea; for alcohol and drug poisoning; allergic reactions, skin diseases (diathesis, neurodermatitis); for burn intoxication; purulent-septic processes accompanied by intoxication; toxicosis of pregnant women in the first half of pregnancy; in complex therapy for intestinal dysbacteriosis.
Contraindication
Acute intestinal obstruction. Individual intolerance to the components of the drug.
Interaction with other medicinal products and other types of interactions
Subject to the method of administration (Enterosgel ExtraCaps and drugs are taken separately), the drug can be used in complex therapy with other drugs and prophylactic agents, including bacterial drugs (bifidum, lactobacilli), herbal preparations, adaptogens, immunomodulators. Simultaneous administration with drugs belonging to the class of bile acid sequestrants, such as cholestyramine, is not recommended due to the increased likelihood of constipation.
The drug should not be used together with silver preparations.
Application features
The drug should be taken according to the recommendations set out in this instruction manual.
Ability to influence reaction speed when driving vehicles or other mechanisms
Does not affect.
Use during pregnancy or breastfeeding
The drug is used during pregnancy or breastfeeding. Use should be limited to pregnant women who are prone to constipation.
Method of administration and doses
Take 1-2 capsules orally 2-3 times a day, 1.5-2 hours before or 2 hours after meals or taking medications, with plenty of water.
For adults and children over 14 years of age, a single dose of the drug is 1-2 capsules, daily dose is 6 capsules.
For children aged 6 to 14 years, a single dose is 1 capsule, daily dose is 3 capsules.
The course of treatment is from 7 to 14 days.
In severe forms of the disease, a double single dose is used during the first 3 days, and in the case of a chronic course of the disease (chronic renal failure, cirrhosis of the liver), longer use of the drug is possible.
Children
The drug can be used in children over 6 years of age. To facilitate swallowing, the capsule (single dose) can be opened and mixed with a small amount of liquid before use.
Overdose
Exceeding the maximum single doses does not cause adverse reactions.
Adverse reactions
Short-term constipation is possible during the first few days of taking the drug. To prevent this, people prone to constipation are recommended to perform a cleansing enema at night or take laxatives (lactulose, sodium picosulfate) during the first two days of using the drug.
Possible manifestations of individual intolerance to the components of the drug.
Expiration date
3 years.
Storage conditions
In the original packaging at a temperature not exceeding 25 °C, out of the reach of children.
Packaging
7 capsules in a blister. 1 blister is placed in a cardboard box.
Vacation category
Without a prescription.
Producer
PJSC KREOMA-PHARM.
Location of the manufacturer and its business address
03680, Ukraine, Kyiv, Radyshcheva St., 3.
